DPI-386 Nasal Gel Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Motion sicknessMotion Sickness, SpaceSea Sickness
Repurposed Therapeutics, Inc.30 enrolled1 locationNCT05886660
Recruiting
Phase 2
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Motion Sickness, SpaceMotion SimulationParabolic Flight
Repurposed Therapeutics, Inc.80 enrolled1 locationNCT05852730